Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Outline of Final Research Achievements |
With advances in high-dose-rate (HDR) brachytherapy, the importance of quality assurance (QA) is increasing to ensure safe delivery of the treatment for cervical cancer. However, conventional QA is time-consuming, involving the use of several different measurement tools. We developed simple QA method for HDR brachytherapy based on the imaging of radiation and evaluated its performance. The method should be highly suitable for quick and easy QA investigations of HDR brachytherapy as it allows measurements of dose distribution, source strength, and source position.
|